Dock Street Asset Management Inc Exelixis, Inc. Transaction History

Dock Street Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 15, 2021	SELL	$20.53 - $25.22 $1.99 Million - $2.45 Million	-97,159 Closed	0 $0
Q4 2020 Jan 27, 2021	SELL	$18.39 - $24.8 $1.75 Million - $2.36 Million	-95,117 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$20.67 - $26.94 $46,507 - $60,615	2,250 Added 2.42%	95,117 $2.33 Million
Q2 2020 Jul 22, 2020	SELL	$16.46 - $27.42 $293,547 - $489,008	-17,834 Reduced 16.11%	92,867 $2.21 Million
Q1 2020 May 06, 2020	BUY	$14.46 - $21.8 $99,369 - $149,809	6,872 Added 6.62%	110,701 $1.91 Million
Q4 2019 Jan 29, 2020	SELL	$15.15 - $18.89 $44,995 - $56,103	-2,970 Reduced 2.78%	103,829 $1.83 Million
Q3 2019 Oct 23, 2019	BUY	$17.68 - $22.65 $3,005 - $3,850	170 Added 0.16%	106,799 $1.89 Million
Q2 2019 Jul 31, 2019	SELL	$18.93 - $24.75 $28,849 - $37,719	-1,524 Reduced 1.41%	106,629 $2.28 Million
Q1 2019 Apr 29, 2019	BUY	$19.6 - $24.76 $2.12 Million - $2.68 Million	108,153 New	108,153 $2.57 Million

502

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Dock Street Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Dock Street Asset Management Inc with notifications on news.